Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: A community practice experience

被引：6
|
作者：
Shen, Huafeng [1 ]
Lipka, Seth [2 ]
Katz, Seymour [3 ,4 ,5 ]
机构：
[1] Nassau Univ, Med Ctr, Dept Med, E Meadow, NY USA
[2] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33612 USA
[3] NYU, Sch Med, New York, NY USA
[4] North Shore Univ Hosp Ong Isl Jewish Hlth Syst, Manhasset, NY USA
[5] St Francis Hosp, Roslyn, NY USA
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷 / 08期
关键词：
D O I：
10.1016/j.crohns.2013.12.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：898 / 899
页数：2
相关论文
共 50 条
  • [31] Malignancy Outcomes in Inflammatory Bowel Disease Patients on Immune Modulators and Anti-Tumor Necrosis Factor Therapy
    Patel, Umangi
    Lichtenstein, Gary
    Scott, Frank
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S484 - S484
  • [32] Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
    Nawaz, Ahmad
    Glick, Laura R.
    Chaar, Abdelkader
    Li, Darrick K.
    Gaidos, Jill K. J.
    Proctor, Deborah D.
    Al-Bawardy, Badr
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (01): : 39 - +
  • [33] Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease
    Sumida, Keiichi
    Shrestha, Prabin
    Mallisetty, Yamini
    Thomas, Fridtjof
    Gyamlani, Geeta
    Streja, Elani
    Kalantar-Zadeh, Kamyar
    Kovesdy, Csaba P.
    JAMA NETWORK OPEN, 2024, 7 (04) : E246822
  • [34] Ten-year outcomes of anti-tumor necrosis factor therapy in inpatients with inflammatory bowel disease
    Tai, J. E.
    Pavli, P.
    Subramaniam, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 148 - 148
  • [35] Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy
    Zanoli, Luca
    Inserra, Gaetano
    Cappello, Maria
    Ozturk, Kadir
    Castellino, Pietro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 981 - 982
  • [36] Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
    Cottone, Mario
    Kohn, Anna
    Daperno, Marco
    Armuzzi, Alessandro
    Guidi, Luisa
    D'Inca, Renata
    Bossa, Fabrizio
    Angelucci, Erika
    Biancone, Livia
    Gionchetti, Paolo
    Ardizzone, Sandro
    Papi, Claudio
    Fries, Walter
    Danese, Silvio
    Riegler, Gabriele
    Cappello, Maria
    Castiglione, Fabiana
    Annese, Vito
    Orlando, Ambrogio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 30 - 35
  • [37] Anti-Tumor Necrosis Factor Treatment of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Jegadeesan, Ramprasad
    Kochhar, Gursimran
    Hayat, Umar
    Kim, Ahyoung J.
    Lan, Nan
    Sanaka, Madhusudhan R.
    Shen, Bo
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2016, 150 (04) : S396 - S397
  • [38] Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
    Ford, Alexander C.
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (08): : 1268 - 1276
  • [39] Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
    Pagnini, Cristiano
    Pizarro, Theresa T.
    Cominelli, Fabio
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [40] Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease
    Blandizzi, C.
    Tuccori, M.
    Ferraro, S.
    Leonardi, L.
    Convertino, I.
    DRUG SAFETY, 2019, 42 (10) : 1245 - 1245
12345